PMID: 33358646
Title: Oral Anticoagulation Continuation Throughout TAVR: High Risk-High Reward or Marginal Gains?

Abstract: N/A

Citation: Auffret V, et al. Oral Anticoagulation Continuation Throughout TAVR: High Risk-High Reward or Marginal Gains?. Oral Anticoagulation Continuation Throughout TAVR: High Risk-High Reward or Marginal Gains?. 2021; 14:145-148. doi: 10.1016/j.jcin.2020.10.026

Link: https://pubmed.ncbi.nlm.nih.gov/33358646/
